Again, NT157 has been found to inhibit glioma cell proliferation and sensitize glioma cells to apoptosis induced by tumor necrosis factor-related apoptosis-induced ligand (TRAIL) via DR5 upregulation [458]. This evidence concerns the gene TNFRSF10B and central nervous system cancer.